Abstract:Background: Cardiac hypertrophy is an important prepathology of, and will ultimately lead to, heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. This study aims to elucidate the effects and mechanisms of HINT1 (histidine triad nucleotide-binding protein 1) in cardiac hypertrophy and heart failure. Methods: HINT1 was downregulated in human hypertrophic heart samples compared with nonhypertrophic samples by mass spectrometry analysis. Hint1 knockout mice were challenged with transverse aortic constriction surgery. Cardiac-specific overexpression of HINT1 mice by intravenous injection of adeno-associated virus 9 (AAV9)-encoding Hint1 under the cTnT (cardiac troponin T) promoter were subjected to transverse aortic construction. Unbiased transcriptional analyses were used to identify the downstream targets of HINT1. AAV9 bearing shRNA against Hoxa5 (homeobox A5) was administrated to investigate whether the effects of HINT1 on cardiac hypertrophy were HOXA5-dependent. RNA sequencing analysis was performed to recapitulate possible changes in transcriptome profile.Coimmunoprecipitation assays and cellular fractionation analyses were conducted to examine the mechanism by which HINT1 regulates the expression of HOXA5. Results: The reduction of HINT1 expression was observed in the hearts of hypertrophic patients and pressure overloaded-induced hypertrophic mice, respectively. In Hint1-deficient mice, cardiac hypertrophy deteriorated after transverse aortic construction. Conversely, cardiac-specific overexpression of HINT1 alleviated cardiac hypertrophy and dysfunction. Unbiased profiler polymerase chain reaction array showed HOXA5 is 1 target for HINT1, and the cardioprotective role of HINT1 was abolished by HOXA5 knockdown in vivo. Hoxa5 was identified to affect hypertrophy through the TGF-beta (transforming growth factor beta) signal pathway. Mechanically, HINT1 inhibited PKC beta 1 (protein kinase C beta type 1) membrane translocation and phosphorylation via direct interaction, attenuating the MEK/ERK/YY1 (mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/yin yang 1) signal pathway, downregulating HOXA5 expression, and eventually attenuating cardiac hypertrophy. Conclusions: HINT1 protects against cardiac hypertrophy through suppressing HOXA5 expression. These findings indicate that HINT1 may be a potential target for therapeutic interventions in cardiac hypertrophy and heart failure.

HSP75 Protects Against Cardiac Hypertrophy and Fibrosis.

Inhibition of TRPC1 Prevents Cardiac Hypertrophy Via NF-κB Signaling Pathway in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Abstract 13694: Hsf1 Attenuates Pressure Overload Induced-cardiac Fibrosis via Inhibiting Smad3 Phosphorylation and Nuclear Translocation

Heat Shock Transcription Factor 1 Protects Against Pressure Overload-Induced Cardiac Fibrosis Via Smad3

Cardiac Secreted-Hsp90alpha in Cardiomyocyte Hypertrophy by N-Cadherin Mediated Signaling under Pressure Overload

Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice

Heat shock transcription factor 1 preserves cardiac angiogenesis and adaptation during pressure overload

Extracellular heat shock protein HSC70 protects against lipopolysaccharide-induced hypertrophic responses in rat cardiomyocytes

Hint1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing Hoxa5 (Homeobox A5) Expression

Small Heat-Shock Protein Hsp20 Attenuates Beta-Agonist-mediated Cardiac Remodeling Through Apoptosis Signal-Regulating Kinase 1.

Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation

Heat Shock Protein 27 Downregulation Attenuates Isoprenaline-Induced Myocardial Fibrosis and Diastolic Dysfunction by Modulating the Endothelial-Mesenchymal Transition

Heat Shock Transcription Factor 1 Regulates Exercise‐induced Myocardial Angiogenesis after Pressure Overload Via HIF‐1α/VEGF Pathway

Extracellular High‐mobility Group Box 1 Mediates Pressure Overload‐induced Cardiac Hypertrophy and Heart Failure

GW25-e0523 Interaction of HSF1 and Smad3 Inhibits Cardiac Fibrosis and Maladaptive Hypertrophy Induced by Pressure Overload

Signal Transducer and Transcriptional Activation 1 Protects Against Pressure Overload‐induced Cardiac Hypertrophy

Hsf1 Attenuates Pressure Overload Induced-Cardiac Fibrosis Via Inhibiting Smad3 Phosphorylation and Nuclear Translocation

The Interactive Association Between Heat Shock Factor 1 and Heat Shock Proteins in Primary Myocardial Cells Subjected to Heat Stress.

Overexpression of heat shock protein 27 against isoproterenol-induced cardiac hypertrophy in a transgenic mouse model

Heat shock protein 90 relieves heat stress damage of myocardial cells by regulating Akt and PKM2 signaling <i>in vivo</i>

HSPA12A acts as a scaffolding protein to inhibit cardiac fibroblast activation and cardiac fibrosis